Evidence map›Paper›PMID 38789888›Full record

SynthesisCurrent nutrition reports2024

Effect of Barley and Oat Consumption on Immune System, Inflammation and Gut Microbiota: A Systematic Review of Randomized Controlled Trials.

María-Engracia Cortijo-Alfonso, María-Paz Romero, Alba Macià, Silvia Yuste, Marian Moralejo, Laura Rubió-Piqué, Carme Piñol-Felis

Abstract readSystematic Review
In one paragraph

Synthesis in Current nutrition reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

María-Engracia Cortijo-AlfonsoUniversity of Lleida-Agrotecnio CERCA Center, Av. Alcalde Rovira Roure 191, 25198, Lleida, Spain.
María-Paz RomeroUniversity of Lleida-Agrotecnio CERCA Center, Av. Alcalde Rovira Roure 191, 25198, Lleida, Spain.
Alba MaciàUniversity of Lleida-Agrotecnio CERCA Center, Av. Alcalde Rovira Roure 191, 25198, Lleida, Spain.
Silvia YusteUniversity of Lleida-Agrotecnio CERCA Center, Av. Alcalde Rovira Roure 191, 25198, Lleida, Spain.
Marian MoralejoUniversity of Lleida-Agrotecnio CERCA Center, Av. Alcalde Rovira Roure 191, 25198, Lleida, Spain.
Laura Rubió-PiquéUniversity of Lleida-Agrotecnio CERCA Center, Av. Alcalde Rovira Roure 191, 25198, Lleida, Spain. laura.rubio@udl.cat.
Carme Piñol-FelisDepartment of Medicine and Surgery, University of Lleida, Lleida, Catalonia, Spain.

Funding

Agency for Management of University and Research Grants (AGAUR) from Generalitat de Catalunya FI AGAUR predoctoral fellowshipNext-Generation European Union funds through the Universitat de Lleida and the Ministerio de Universidades Ayudas Margarita Salas
6 · The paper itself

Abstract

purpose of reviewThe aim of this systematic review was to investigate the effects of whole grain Avena sativa and Hordeum vulgare L., or their isolated fractions, on immune and inflammatory functions, as well as their influence on gut microbiota. A structured literature search was undertaken in line with PRISMA guidelines. Randomized controlled trials (RCTs) that investigated the effects of oats or barley consumption in adults and reported ≥ 1 of the following: C-reactive protein (CRP), tumor necrosis factor (TNF-α), interleukin-6 (IL-6), IL-2, IL-8, IL-18, lipopolysacharide binding protein (LBP) or gut microbiota-related outcomes, were included. RECENT

findingsA total of 16 RCTs were included, among which 6 studies recruited metabolically at-risk population, including individuals with overweight and obesity, metabolic syndrome or hypercholesterolemia. Additionally, 3 trials involved young healthy population, 5 trials targeted older individuals (aged over 50 years), and 2 studies encompassed populations with other disease states. A total of 1091 individuals were included in the evaluation of short-term (up to 14 days) and long-term (beyond 14 days, up to 90 days) supplementation with oats or barley-based products. 9 studies measured inflammatory biomarkers and 5 of them reported significant reductions, specifically in long-term studies. Notably, no evidence of anti-inflammatory benefits was found in healthy individuals, whereas studies involving metabolically at-risk populations showed promising reductions in inflammation. 13 studies measured the impact on gut microbiota, and collectively suggest that oats and barley food products can influence the composition of gut microbiota, associated in some cases with metabolic improvements. Oats and barley consumption may confer anti-inflammatory effects in metabolically at-risk populations and influence gut microbiota outcomes. However, no anti-inflammatory benefits were observed in healthy individuals. Results from this systematic review suggests caution in interpreting findings due to limited trials and variations in interventions and health conditions.

Indexed as

AvenaGastrointestinal MicrobiomeHordeumInflammationAcute-Phase ProteinsCarrier ProteinsC-Reactive ProteinDietHumansImmune SystemLipopolysaccharide-Binding ProteinMembrane GlycoproteinsRandomized Controlled Trials as TopicWhole GrainsAcute-Phase ProteinsCarrier ProteinsC-Reactive ProteinLipopolysaccharide-Binding ProteinMembrane GlycoproteinsBarleyGut microbiotaImmune functionInflammationOatsSystematic reviewβ-glucans

Identifiers

PMID38789888
PMCPMC11327181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.